Startup based in the United States, most recent round Seed, 1 tracked investor.
Based in the United States, Convexia is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Convexia is an AI-driven pharmaceutical platform that uses autonomous software agents to source overlooked preclinical candidates, run computational biology models (e.g., ESM-3, RFdiffusion, AlphaFold) to assess safety and efficacy in silico, and simulate clinical trials and commercial outcomes to advance programs toward Phase 1.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.